Stocks-CYTK-Cytokinetics Inc

CYTK Cytokinetics Inc

36.23 0.24 (0.65%)
in USD Market Open
Invest
Invest

Overview

Prev Close36.00
Day's Range 35.45 - 38.73
52 Week Range 29.06 - 55.77
Average Volume (3m)1.1M
1-Year Return2.54%
Beta0.965
Market Cap3.41B
P/E Ratio
Revenue148.23M
EPS-3.1649
Dividend (Yield)0 (0%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Chart times in UTC
Industry Pharmaceuticals Major
CEO Robert I. Blum, MBA
Employees 253

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2021: Cytokinetics Inc's revenues increased by 26.15% and amounted to 70.43M. Net income decreased by 69.15% to -215.31M. Net assets increased by 115.08% to 243.86M and EPS decreased from -1.97 to -2.80.
CYTK's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
94.37%
Net Profit Margin
-456.00%
Operating Margin
-147.66%
Return On Investment
-89.43%
12/21
03/22
06/22
09/22
Total Revenue
55.6M
1.15M
88.97M
2.52M
Gross Profit
N/A
N/A
N/A
N/A
Operating Income
-21.7M
-77.86M
-10.87M
-108.44M
Net Income
-30.57M
-89.45M
-19.82M
-142.31M